Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Thomas

Showing results (291-300 of 310) with videos related to

Pageof 31
Sort By:
Journal of Clinical Immunology|July 1, 1982
T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host diseaseG Janossy, L Montano, W S Selby, et al.
Journal of Viral Hepatitis|January 19, 2005
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialM Wright, D Forton, J Main, et al.
East African Medical Journal|November 1, 1995
Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver diseaseO S Ojo, M Thursz, H C Thomas, et al.
The Journal of Infectious Diseases|April 1, 1994
Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.
Journal of Viral Hepatitis|January 14, 2012
Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammationV P B Grover, N Pavese, S-B Koh, et al.
Journal of Viral Hepatitis|December 17, 2009
Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis CA K P Lim, N Patel, R J Eckersley, et al.
Journal of Molecular and Cellular Cardiology|May 9, 1998
Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3T L Yue, C Wang, A M Romanic, et al.
Gut|December 14, 2004
Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis CA K P Lim, S D Taylor-Robinson, N Patel, et al.
Journal of Viral Hepatitis|October 7, 2009
Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis CJ F L Cobbold, M M E Crossey, P Colman, et al.
Pageof 31

Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
Journal of Clinical Immunology|July 1, 1982
T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host diseaseG Janossy, L Montano, W S Selby, et al.
Journal of Viral Hepatitis|January 19, 2005
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialM Wright, D Forton, J Main, et al.
East African Medical Journal|November 1, 1995
Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver diseaseO S Ojo, M Thursz, H C Thomas, et al.
The Journal of Infectious Diseases|April 1, 1994
Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.
Journal of Viral Hepatitis|January 14, 2012
Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammationV P B Grover, N Pavese, S-B Koh, et al.
Journal of Viral Hepatitis|December 17, 2009
Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis CA K P Lim, N Patel, R J Eckersley, et al.
Journal of Molecular and Cellular Cardiology|May 9, 1998
Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3T L Yue, C Wang, A M Romanic, et al.
Gut|December 14, 2004
Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis CA K P Lim, S D Taylor-Robinson, N Patel, et al.
Journal of Viral Hepatitis|October 7, 2009
Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis CJ F L Cobbold, M M E Crossey, P Colman, et al.
Pageof 31